DNA methylation is a reversible epigenetic phenomenon that can be modified by nutrients such as folate and influenced by the MTHFR677C>T polymorphism in a gene-nutrient interaction manner. In human cancer, global DNA hypomethylation is an almost universal finding.Cancer subjects had lower plasma folate concentrations (P=0.003), higher frequency of MTHFR677TT (P=0.013) and lower PBMCs-DNA methylation than controls (P<0.0001). A DNA methylation threshold of 4.74% categorized cancer patients from controls. Subjects with cancer at follow-up had at enrollment lower DNA methylation than controls (P<0.0001). The association of MTHFR677TT and low plasma folate showed the lowest DNA methylation levels (4.39%). Cancer deaths had a lower DNA methylation compared with other cause deaths (P=0.015) and the survivors had an increased DNA methylation compared to cancer (P=0.004). Low global DNA methylation in PBMCs may be a useful predictive biomarker of cancer.

Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk

GUARINI, Patrizia;Udali, Silvia;PATTINI, Patrizia;MORUZZI, Sara;GIRELLI, Domenico;PIZZOLO, Francesca;MARTINELLI, Nicola;OLIVIERI, Oliviero;FRISO, Simonetta
2013

Abstract

DNA methylation is a reversible epigenetic phenomenon that can be modified by nutrients such as folate and influenced by the MTHFR677C>T polymorphism in a gene-nutrient interaction manner. In human cancer, global DNA hypomethylation is an almost universal finding.Cancer subjects had lower plasma folate concentrations (P=0.003), higher frequency of MTHFR677TT (P=0.013) and lower PBMCs-DNA methylation than controls (P<0.0001). A DNA methylation threshold of 4.74% categorized cancer patients from controls. Subjects with cancer at follow-up had at enrollment lower DNA methylation than controls (P<0.0001). The association of MTHFR677TT and low plasma folate showed the lowest DNA methylation levels (4.39%). Cancer deaths had a lower DNA methylation compared with other cause deaths (P=0.015) and the survivors had an increased DNA methylation compared to cancer (P=0.004). Low global DNA methylation in PBMCs may be a useful predictive biomarker of cancer.
epigenetics; DNA methylation; cancer; cancer biomarkers; peripheral blood methylation; peripheral blood biomarker; MTHFR polymorphism; one-carbon metabolism; folate metabolism; diet and cancer
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11562/479755
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 57
  • ???jsp.display-item.citation.isi??? ND
social impact